science

Ublituximab

Ublituximab is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Ublituximab rather than just read about it. In short: Ublituximab, sold under the brand name Briumvi, is an immunomodulator used for the treatment of multiple sclerosis. It is a CD20-directed cytolytic monoclonal antibody.

Key takeaways

Ublituximab belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Ublituximab to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Ublituximab from memory before moving on to harder problems.

Reference excerpt

Ublituximab, sold under the brand name Briumvi, is an immunomodulator used for the treatment of multiple sclerosis. It is a CD20-directed cytolytic monoclonal antibody. The most common adverse reactions include infusion reactions, including fever, chills, headache, influenza-like illness, elevated heart rate, nausea, throat irritation, reddening of the skin (erythema) and an anaphylactic (allergic) reaction; infections including serious and fatal bacterial, fungal, and new or reactivated viral infections and reduction in immunoglobulins. It was approved for medical use in the United States in December 2022, and in the European Union in May 2023.

Medical uses Ublituximab is indicated for the treatment of relapsing forms of multiple sclerosis.

History Ublituximab was designed as part of a research program by the French Laboratory of Fractionation and Biotechnology, with the initial objective of addressing a clinical need in chronic B-lymphocytic leukemia. The design of ublituximab has been optimized to enhance the activation of killer immune cells while minimizing side effects, through modifications to its structure and glycosylation. After clinical trials confirming its strong cytotoxic activity and ability to eliminate B cells, the development of ublituximab was pursued by the American biopharmaceutical company TG Therapeutics. The US Food and Drug Administration approved ublituximab based on evidence from two clinical trials of 1,093 participants with relapsing forms of multiple sclerosis. The trials were conducted at 110 of sites in 10 countries in North America and Europe. The trials were used to assess both efficacy and safety of ublituximab. Participants received ublituximab or teriflunomide for up to 96 weeks. Neither the participants nor the health care providers knew which treatment was being given until the trials were completed. The benefit of ublituximab was evaluated based on the annualized relapse rate, or the number of relapses per year, over the treatment period.

Society and culture

Legal status Ublituximab was approved for medical use in the United States in December 2022, and in the European Union in May 2023.

Names Ublituximab is the international nonproprietary name (INN). Ublituximab is sold under the brand name Briumvi.

References

Worked examples

Example 1 — a first encounter with Ublituximab

Start with the simplest possible case. Write down what Ublituximab claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Ublituximab before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Ublituximab ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Ublituximab

In research: Ublituximab appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Ublituximab in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Ublituximab is common in secondary-school and first-year university syllabi. It links to neighbouring topics Monoclonal antibodies, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life: Look for Ublituximab outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Ublituximab” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Ublituximab in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Ublituximab means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Ublituximab out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Ublituximab in simple terms?

Ublituximab, sold under the brand name Briumvi, is an immunomodulator used for the treatment of multiple sclerosis. It is a CD20-directed cytolytic monoclonal antibody.

Why does Ublituximab matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Ublituximab?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Ublituximab.